Vitiligo is an autoimmune disorder characterized by ivory-white patches secondary to melanocyte destruction. The disease is inherited as autosomal dominant with variable penetrance and is estimated to affect 1–2% of the population.1 Thirty percent of patients have either a positive family history of vitiligo or a history of halo nevi or premature hair graying.2,3 Vitiligo usually affects young adults, with 50% of cases occurring before the age of 20 and 25% before the age of 8 years.4 The disease is uncommon in infancy. In most cases, symmetrical lesions develop on sunexposed areas like the dorsa of hands, the face, and neck.5 Other favored sites include body folds like the axilla and groin and body orifices such as the mouth, nose, umbilicus, genitalia, and anus. Vitiligo lesions can also arise over bony prominences like the elbows and knees. Lesions are usually variable in size and shape and consist of well-defined depigmented macules and patches. Loss of pigment may not be apparent in fairskinned individuals but may be disfiguring in blacks. Vitiligo can appear at sites of trauma or sunburn (Koebner’s phenomenon). A variant of vitiligo is the segmental type, which consists of asymmetrically distributed, depigmented macules confined to one nerve segment (Fig 1). This form is more common in children and is highly associated with autoimmune disorders and premature graying.6 Associations There is a 10–20% incidence of vitiligo in endocrine autoimmune disorders like Hashimoto’s thyroiditis, diabetes mellitus, polyendocrine deficiencies, and parathyroid abnormalities.7 In addition, patients with lymphoma, leukemia, myasthenia gravis, scleroderma, and alopecia areata have a higher incidence of vitiligo. It is estimated that 20% of patients with malignant melanoma have vitiligo, and its presence is a poor prognostic factor.2,8 Vitiligo patients are prone to multiple ocular abnormalities, including discrete depigmentation in the choroid and retinal pigment epithelium, chorioretinitis, uveitis, and iritis. The Vogt-Koyanagi-Harada syndrome is a rare disorder characterized by bilateral uveitis, alopecia, vitiligo, deafness, and possible meningeal irritation.9 The Alezzandrini syndrome consists of bilateral deafness with unilateral degenerative retinitis, unilateral vitiligo and poliosis.10 The differential diagnosis of vitiligo includes postinflammatory hypopigmentation, pityriasis alba, tinea versicolor, albinism, and the ash leaf macule of tuberous sclerosis.